18:18:43 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Dalradian Resources Inc
Symbol DNA
Shares Issued 109,380,483
Close 2014-07-07 C$ 1.00
Market Cap C$ 109,380,483
Recent Sedar Documents

Dalradian arranges $21.6-million offering, placement

2014-07-08 15:45 ET - News Release

Ms. Marla Gale reports

DALRADIAN ANNOUNCES FINANCINGS TO RAISE GROSS PROCEEDS EXCEEDING C$20 MILLION

Dalradian Resources Inc. has entered into an agreement with Canaccord Genuity Corp. as lead underwriter, pursuant to which it, along with a syndicate to be formed, have agreed to purchase, on a bought-deal basis pursuant to a short-form prospectus, 11.2 million units of the company at a price of 90 cents per unit for gross proceeds of $10.08-million. Each unit shall consist of one common share of the company and one-half of one common share purchase warrant. Each warrant shall be exercisable for one common share of the company for a period of 36 months from the closing date (as herein defined) at an exercise price of $1.50.

In addition, the company has granted the underwriters an option to purchase additional units at the offering price to raise additional gross proceeds of up to 15 per cent of the underwritten offering, for a period of 30 days after, and including, the closing date to cover overallotments, if any, and for market stabilization purposes.

The company has also agreed to complete a concurrent non-brokered private placement of 11.2 million units at the offering price for additional aggregate gross proceeds of $10.08-million. Units in the concurrent placement will be subscribed for by clients and affiliates of Sprott Private Wealth LP.

The net proceeds from the offering and the concurrent placement are expected to be used by the company for exploration and development activities at the company's Curraghinalt gold project and for general working capital purposes.

Closing of the offering is conditional upon the completion of the concurrent placement for approximately $10-million, both of which are anticipated to occur on or around July 31, 2014, and is subject to certain conditions including, but not limited to, the receipt of all applicable regulatory approvals including approval of the Toronto Stock Exchange.

The units to be issued under the offering will be offered by way of a short-form prospectus in each of the provinces of Canada, except Quebec. The units to be issued under the concurrent placement will be offered pursuant to the accredited investor exemption under National Instrument 45-106 in each of the provinces of Canada, except Quebec. The units issued pursuant to the concurrent placement, and all securities issuable thereunder, will be subject to a statutory hold period under Canadian securities legislation for four months and one day following the closing date. The units to be issued under the offering and the concurrent placement may also be offered in the United States on a private-placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended, and certain other jurisdictions in accordance with applicable securities laws.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.